Women's Center
Deliver in the tranquility and comfort of our newly renovated private guest suites.

James E. Kendrick, MD

Biographical Sketch

A graduate of the University of Alabama, Dr. James E. Kendrick IV brings years of expertise to the Florida Hospital Cancer Institute, particularly in the area of uterine cancer and gynecologic oncology.

After earning his medical degree at the University of Alabama’s School of Medicine, Dr. Kendrick completed his residency in Obstetrics and Gynecology at the university’s hospital. He also completed his three-year fellowship there. Dr. Kendrick’s interests include robotic surgery and gynecological malignancy management.

He is a noted author of peer-reviewed articles, publications and abstracts, with nearly 50 published works to his credit.

Professional Highlights

  • Medical Staff, Florida Hospital Cancer Institute
  • Fellow/Instructor, University of Alabama Hospital

Education & Fellowships

Fellowship: Gynecologic Oncology, University of Alabama Hospital at Birmingham

Residency: Obstetrics and Gynecology, University of Alabama Hospital

Medical School: University of Alabama at Birmingham, School of Medicine

Undergraduate: University of Alabama


American College of Obstetricians and Gynecologists


Obstetrics and Gynecology (ABOG) – board eligible

Gynecology Oncology – board eligible


  • Uterine Cancer
  • Robotic Surgery

Professional Memberships

American College of Obstetricians & Gynecology

American Society of Clinical Oncology

Society of Gynecologic Oncologists

Research & Publications

Dr. Kendrick has authored and co-authored nearly 50 works for publication, including:

Leath CA III, Numnum TM, Kendrick JE IV, Frederick PJ, Rocconi RP, Conner MG, Straughn JM Jr. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: Implications for adjuvant therapy. International Journal of Gynecologic Cancer.

Kendrick JE, Numnum TM, Estes JM, Kimball KJ, Leath CA, Straughn JM. Conservative Management of Postoperative Fever in Gynecologic Patients Undergoing Major Abdominal or Vaginal Surgery. Journal of the American College of Surgeons.

Kendrick JE, Straughn JM, Oliver PG, Wang W, Nan L, Grizzle WE, Stockard CR, Alvarez RD, Buchsbaum DJ. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model. Gynecologic Oncology; 108(3): 591-7, March 2008.

Kendrick JE, Huh WK. Treatment Considerations in Advanced Endometrial Cancer. Current Oncology Reports 2007; 9(6): 494-498.

Kendrick JE, Estes JM, Straughn JM, Alvarez RD, Buchsbaum DJ. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and its Therapeutic Potential in Breast and Gynecologic Cancers. Gynecologic Oncology; 106(3):614­21, June 2007.

For more information call 407-303-4HER